Back
Sep 28
Clinical Trials
CT 01 - Clinical Trials
MODERATOR(S)
Kenneth Rosenzweig, MD, FASTRO - Icahn School of Medicine at Mount Sinai
Farzan Siddiqui, MD, PhD, FASTRO - Henry Ford Hospital/Wayne State University
Credits
| AMA PRA Category 1 Credits: | 1.50 |
Presentations
-
01:00pm - 02:30pm PT
Clinical Trials
Speaker: Kenneth Rosenzweig, MD, FASTRO - Icahn School of Medicine at Mount Sinai, New York -
01:00pm - 02:30pm PT
Clinical Trials
Speaker: Farzan Siddiqui, MD, PhD, FASTRO - Henry Ford Hospital/Wayne State University, Detroit -
01:00pm - 01:10pm PT
A Double-Blinded Placebo-Controlled Biomarker Stratified Randomized Trial of Apalutamide (APA) and Radiotherapy for Recurrent Prostate Cancer (NRG GU006, BALANCE trial)
Speaker: Daniel Spratt, MD - University Hospitals Seidman Cancer Center, Case Western Reserve University, Beachwood -
01:10pm - 01:20pm PT
-
01:20pm - 01:30pm PT
Androgen Deprivation Therapy (ADT) and High Dose Definitive Radiotherapy (RT) +/- Whole Pelvic RT in Patients with Unfavorable Intermediate or Favorable High-Risk Prostate Cancer: Early Results of a Phase III Randomized Controlled Trial
Speaker: Mack Roach, MD, PhD, FASTRO - University of California San Francisco, San Francisco -
01:30pm - 01:40pm PT
Toxicities and Quality of Life Following Observation or Radiation Therapy for Dupuytren's Disease in the International DEPART Randomized Trial
Speaker: Jarad Martin, MD, MB, ChB, PhD, BSc FRANZCR GAustMS - Calvary Mater Newcastle Hospital, Newcastle -
01:40pm - 01:50pm PT
Clinical Effectiveness of Single Course Low-Dose Radiation Therapy in Knee Osteoarthritis: Short-term Results from the Randomized, Sham-Controlled Trial
Speaker: Byoung Hyuck Kim, MD, PhD - SMG-SNU Boramae Medical Center, Seoul -
01:50pm - 02:00pm PT
Decreasing the Dose of Consolidation Radiation Therapy in DLBCL/HGBL: A Phase II Trial by the International Lymphoma Radiation Oncology Group
Speaker: Christopher Kelsey, MD, FASTRO - Duke University Medical Center, Durham -
02:00pm - 02:10pm PT